Contamac introduces HyClear, the next generation hypochlorous acid .01% solution for daily eyelid health management.
HyClear – a Class II medical device – will provide a pure and stable form of hypochlorous acid that is both affordable and convenient for the patient.
HyClear is manufactured utilizing a new proprietary manufacturing process that provides a pure, stable and effective solution for daily dry eye management.
Marty Dalsing, President for Contamac U.S. commented, “There is a huge opportunity in the market for a state of the art hypochlorous acid product that is as effective as other similar products in the marketplace and offers a more stable formulation. HyClear will be an exclusive Optometrist and Ophthalmologist brand providing an affordable regimen for their patients and a consistent, reliable revenue stream for the dry eye and contact lens segments of their practices.”
Pure – HyClear delivers all the activity of pure hypochlorous acid .01%, killing most ocular pathogens in solution in 15 seconds*. HyClear encompasses the broad-spectrum antimicrobial activity of pure hypochlorous acid .01% and is also a non-cytotoxic, non-irritating and comfortable solution.
Stable – the HyClear manufacturing process produces a balanced formulation with 18 months shelf life. It comes in a safe plastic bottle with a patient-friendly spray pump.
Affordable – HyClear will provide an affordable daily eyelid health management solution for all patients.
Exclusive – HyClear is an exclusive brand for Optometrists and Ophthalmologists for sale directly to their patients.
HyClear is intended to be dispensed by and under the supervision of the Optometrist or Ophthalmologist directly to their patients.
HyClear is currently only available in the United States.
*15 seconds in solution. Reduction in microbial growth in solution has not shown to correlate with a reduction of infection in patients. No clinical studies have been performed to evaluate reduction of infection.